127 related articles for article (PubMed ID: 11600458)
21. [Indications and use of omeprazole in esophago-gastro-duodenal diseases].
Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A
Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238
[No Abstract] [Full Text] [Related]
22. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2. Use of intravenous omeprazole in gastrointestinal patients before endoscopy.
Tai CK
Emerg Med J; 2008 Nov; 25(11):765. PubMed ID: 18955620
[No Abstract] [Full Text] [Related]
23. Intravenous eradication therapy for bleeding gastroduodenal ulcer associated with Helicobacter pylori infection.
Romero Gómez M; Martínez Delgado C; Grande L; Otero Fernández MA; Vargas J; Castro Fernández M
Rev Esp Enferm Dig; 2000 Jun; 92(6):386-91. PubMed ID: 10985098
[TBL] [Abstract][Full Text] [Related]
24. Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer.
Kamada T; Hata J; Kusunoki H; Kido S; Hamada H; Aoki R; Nishida T; Komoto K; Todo H; Sumioka M; Tanimoto T; Sanuki E; Sumii K; Ogoshi H; Hidaka T; Dongmei Q; Chayama K; Haruma K
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():73-8. PubMed ID: 15943851
[TBL] [Abstract][Full Text] [Related]
25. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
26. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
[TBL] [Abstract][Full Text] [Related]
28. 0.5 mg/kg versus 1 mg/kg of intravenous omeprazole for the prophylaxis of gastrointestinal bleeding in critically ill children: a randomized study.
Solana MJ; López-Herce J; Sánchez A; Sánchez C; Urbano J; López D; Carrillo A
J Pediatr; 2013 Apr; 162(4):776-782.e1. PubMed ID: 23149178
[TBL] [Abstract][Full Text] [Related]
29. Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.
Hsieh YH; Lin HJ; Tseng GY; Perng CL; Wang K; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(55):316-9. PubMed ID: 15011893
[TBL] [Abstract][Full Text] [Related]
30. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
[TBL] [Abstract][Full Text] [Related]
31. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots.
Jung HK; Son HY; Jung SA; Yi SY; Yoo K; Kim DY; Moon IH; Lee HC
Am J Gastroenterol; 2002 Jul; 97(7):1736-40. PubMed ID: 12135028
[TBL] [Abstract][Full Text] [Related]
32. Recurrent peptic ulcer disease in a pediatric patient with type 1 neurofibromatosis and primary ciliary dyskinesia.
Lionetti E; Francavilla R; Ruggieri M; Di Stefano V; Principi MB; Pavone L
Minerva Pediatr; 2009 Oct; 61(5):557-9. PubMed ID: 19794381
[TBL] [Abstract][Full Text] [Related]
33. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
Triadafilopoulos G
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
[TBL] [Abstract][Full Text] [Related]
34. Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients.
Udd M; Miettinen P; Palmu A; Julkunen R
Scand J Gastroenterol; 2003 Jun; 38(6):588-93. PubMed ID: 12825865
[TBL] [Abstract][Full Text] [Related]
35. Omeprazole and bleeding peptic ulcer, or "how case-control studies can tell you what you suspected all along".
Hawkey CJ
Epidemiology; 1999 May; 10(3):211-3. PubMed ID: 10230826
[No Abstract] [Full Text] [Related]
36. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.
van Rensburg CJ; Hartmann M; Thorpe A; Venter L; Theron I; Lühmann R; Wurst W
Am J Gastroenterol; 2003 Dec; 98(12):2635-41. PubMed ID: 14687809
[TBL] [Abstract][Full Text] [Related]
37. Continuous infusion or repeated intravenous bolus injection of high-dose omeprazole in patients at high risk of rebleeding from peptic ulcers?
Netzer P; Inauen W
Am J Gastroenterol; 2006 Dec; 101(12):2888-9; author reply 2889. PubMed ID: 17227532
[No Abstract] [Full Text] [Related]
38. Gastrointestinal bleeding: adjuvant pharmacotherapy for peptic ulcer bleeding.
Hsu YC; Lin HJ
Nat Rev Gastroenterol Hepatol; 2009 Aug; 6(8):450-2. PubMed ID: 19654601
[No Abstract] [Full Text] [Related]
39. Anaphylaxis to lansoprazole with tolerance to omeprazole.
Aksu K; Kurt E
Allergol Immunopathol (Madr); 2012; 40(6):393-4. PubMed ID: 22115571
[No Abstract] [Full Text] [Related]
40. Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.
Yeomans ND
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):447-55. PubMed ID: 21780891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
